Ditchcarbon
  • Customers
  1. Organizations
  2. Wuxi Biologics
Public Profile
Medical Device Manufacturing
CN
updated 15 days ago

Wuxi Biologics

Company website

Wuxi Biologics, officially known as WuXi AppTec Co., Ltd., is a leading global contract research, development, and manufacturing organisation (CDMO) headquartered in Wuxi, China. Founded in 2010, the company has rapidly expanded its operations across major regions, including the United States and Europe, establishing itself as a key player in the biopharmaceutical industry. Specialising in biologics, Wuxi Biologics offers a comprehensive range of services, from cell line development to commercial manufacturing. Their unique integrated platform streamlines the drug development process, enabling clients to bring innovative therapies to market more efficiently. With a strong commitment to quality and innovation, Wuxi Biologics has achieved significant milestones, including numerous partnerships with leading pharmaceutical companies, solidifying its position as a trusted partner in the global biopharmaceutical landscape.

DitchCarbon Score

How does Wuxi Biologics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

54

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

27

Industry Benchmark

Wuxi Biologics's score of 54 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

74%

Let us know if this data was useful to you

Wuxi Biologics's reported carbon emissions

In 2024, Wuxi Biologics reported total greenhouse gas emissions of approximately 198,654,000 kg CO2e, comprising 38,346,000 kg CO2e from Scope 1 and 160,308,000 kg CO2e from Scope 2 emissions. Additionally, Scope 3 emissions included 24,700,000 kg CO2e from business travel, 19,176,000 kg CO2e from employee commuting, and 58,680,000 kg CO2e from fuel and energy-related activities, among other categories. The company has set ambitious climate commitments, aiming to achieve net-zero greenhouse gas emissions across its value chain by 2050. Near-term targets include a reduction of absolute Scope 1 and 2 emissions by 58.8% by 2034 from a 2024 base year, and a 63.8% reduction in Scope 3 emissions related to purchased goods and services per kg of product produced within the same timeframe. Long-term goals include a 90% reduction in both Scope 1 and 2 emissions and Scope 3 emissions by 2050, also from a 2024 base year. Wuxi Biologics' mid-term goal is to reduce Scope 1 and 2 GHG emission intensity by 50% (tonnes/RMB10,000) by 2030 from a 2020 base year. These targets are aligned with the Science Based Targets initiative (SBTi) and are classified under the 1.5°C pathway, demonstrating the company's commitment to addressing climate change effectively.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20202021202220232024
Scope 1
11,042,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
74,361,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
00,000,000
00,000,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Wuxi Biologics's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Wuxi Biologics is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Wuxi Biologics is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Lonza

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 19 hours ago

Samsung Biologics

KR
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Senti Biosciences, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 20 days ago

IQVIA Inc.

US
•
Research and development services (73)
Updated 3 days ago

Catalent

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Akums Drugs and Pharmaceuticals Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250916.8
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy